154 related articles for article (PubMed ID: 25892185)
1. Inhibition of PMCA activity by tau as a function of aging and Alzheimer's neuropathology.
Berrocal M; Corbacho I; Vázquez-Hernández M; Ávila J; Sepúlveda MR; Mata AM
Biochim Biophys Acta; 2015 Jul; 1852(7):1465-76. PubMed ID: 25892185
[TBL] [Abstract][Full Text] [Related]
2. The Plasma Membrane Ca
Berrocal M; Mata AM
Neuroscience; 2023 May; 518():112-118. PubMed ID: 35469971
[TBL] [Abstract][Full Text] [Related]
3. Phospholipids and calmodulin modulate the inhibition of PMCA activity by tau.
Berrocal M; Corbacho I; Sepulveda MR; Gutierrez-Merino C; Mata AM
Biochim Biophys Acta Mol Cell Res; 2017 Jun; 1864(6):1028-1035. PubMed ID: 27818274
[TBL] [Abstract][Full Text] [Related]
4. Methylene blue activates the PMCA activity and cross-interacts with amyloid β-peptide, blocking Aβ-mediated PMCA inhibition.
Berrocal M; Corbacho I; Gutierrez-Merino C; Mata AM
Neuropharmacology; 2018 Sep; 139():163-172. PubMed ID: 30003902
[TBL] [Abstract][Full Text] [Related]
5. Altered Ca2+ dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain affected by Alzheimer's disease.
Berrocal M; Marcos D; Sepúlveda MR; Pérez M; Avila J; Mata AM
FASEB J; 2009 Jun; 23(6):1826-34. PubMed ID: 19144698
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin antagonizes amyloid-β peptides-mediated inhibition of brain plasma membrane Ca(2+)-ATPase.
Berrocal M; Sepulveda MR; Vazquez-Hernandez M; Mata AM
Biochim Biophys Acta; 2012 Jun; 1822(6):961-9. PubMed ID: 22525477
[TBL] [Abstract][Full Text] [Related]
7. Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer's Disease on the Pump Activity.
Berrocal M; Saez L; Mata AM
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205207
[TBL] [Abstract][Full Text] [Related]
8. Methylene Blue Blocks and Reverses the Inhibitory Effect of Tau on PMCA Function.
Berrocal M; Caballero-Bermejo M; Gutierrez-Merino C; Mata AM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31323781
[TBL] [Abstract][Full Text] [Related]
9. Functional interplay between plasma membrane Ca
Mata AM
Neurosci Lett; 2018 Jan; 663():55-59. PubMed ID: 28780168
[TBL] [Abstract][Full Text] [Related]
10. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part V: why is Ca2+ signal lower in the disease?
Chen M; Fernandez HL
Front Biosci; 1999 Apr; 4():A9-15. PubMed ID: 10099137
[TBL] [Abstract][Full Text] [Related]
11. Impairment of the activity of the plasma membrane Ca²⁺-ATPase in Alzheimer's disease.
Mata AM; Berrocal M; Sepúlveda MR
Biochem Soc Trans; 2011 Jun; 39(3):819-22. PubMed ID: 21599654
[TBL] [Abstract][Full Text] [Related]
12. The plasma membrane calcium pumps-The old and the new.
Zaidi A; Adewale M; McLean L; Ramlow P
Neurosci Lett; 2018 Jan; 663():12-17. PubMed ID: 29452610
[TBL] [Abstract][Full Text] [Related]
13. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?
Schnurra I; Bernstein HG; Riederer P; Braunewell KH
Neurobiol Dis; 2001 Oct; 8(5):900-9. PubMed ID: 11592857
[TBL] [Abstract][Full Text] [Related]
14. Cofilin rods and aggregates concur with tau pathology and the development of Alzheimer's disease.
Rahman T; Davies DS; Tannenberg RK; Fok S; Shepherd C; Dodd PR; Cullen KM; Goldsbury C
J Alzheimers Dis; 2014; 42(4):1443-60. PubMed ID: 25024349
[TBL] [Abstract][Full Text] [Related]
15. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
16. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction.
Yu CH; Song GS; Yhee JY; Kim JH; Im KS; Nho WG; Lee JH; Sur JH
J Comp Pathol; 2011 Jul; 145(1):45-58. PubMed ID: 21256508
[TBL] [Abstract][Full Text] [Related]
17. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.
Lüth HJ; Ogunlade V; Kuhla B; Kientsch-Engel R; Stahl P; Webster J; Arendt T; Münch G
Cereb Cortex; 2005 Feb; 15(2):211-20. PubMed ID: 15238435
[TBL] [Abstract][Full Text] [Related]
18. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
Gironès X; Guimerà A; Cruz-Sánchez CZ; Ortega A; Sasaki N; Makita Z; Lafuente JV; Kalaria R; Cruz-Sánchez FF
Free Radic Biol Med; 2004 May; 36(10):1241-7. PubMed ID: 15110389
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta, tau, and dementia.
Takashima A
J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626
[TBL] [Abstract][Full Text] [Related]
20. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
